Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
11
100%

Phase Distribution

0

Early Stage

0

Mid Stage

11

Late Stage

Phase Distribution11 total trials
Phase 3Large-scale testing
11(100.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

11 of 11 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(11)

Detailed Status

Completed11

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 311 (100.0%)

Trials by Status

completed11100%

Recent Activity

0 active trials
Showing 5 of 11
completedphase_3

Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-803)

NCT00092625
completedphase_3

Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036)

NCT00092560
completedphase_3

An Investigational Drug Study to Lower Non-Cholesterol Sterol Levels Associated With Sitosterolemia (0653-062)(COMPLETED)

NCT00092898
completedphase_3

Sitosterolemia Extension Study (0653-003)(COMPLETED)

NCT00092807
completedphase_3

Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-802)(COMPLETED)

NCT00092612
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT00092625Phase 3

Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-803)

Completed
NCT00092560Phase 3

Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036)

Completed
NCT00092898Phase 3

An Investigational Drug Study to Lower Non-Cholesterol Sterol Levels Associated With Sitosterolemia (0653-062)(COMPLETED)

Completed
NCT00092807Phase 3

Sitosterolemia Extension Study (0653-003)(COMPLETED)

Completed
NCT00092612Phase 3

Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-802)(COMPLETED)

Completed
NCT00092638Phase 3

An Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-804)(COMPLETED)

Completed
NCT00328523Phase 3

TWICE (Ezetimibe Together With Any Statin Cholesterol Enhancement)(0653-060)

Completed
NCT00092573Phase 3

Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia (0653-036)(COMPLETED)

Completed
NCT00092586Phase 3

Study of an Approved Drug With a Statin (a Medication That Lowers Cholesterol Levels) as Compared to Statin Therapy Alone in Patients With High Cholesterol (0653-040)

Completed
NCT00092599Phase 3

Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-801)

Completed
NCT00092820Phase 3

Sitosterolemia Extension Study (0653-004)(COMPLETED)

Completed

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11